The PJ Pod
The PJ Pod keeps you one step ahead of developments in pharmacy, medicines and the pharmaceutical sciences. It is brought to you by the team behind The Pharmaceutical Journal.
Episodes
Spotlight: The battle for EPS nominations
Electronic Prescription System (EPS) nominations connect patients with the pharmacy where they can collect their medication – and often access other services, help and advice while they’re there.
Only patients can set up or change their nominated pharmacy – it can’t be done by the pharmacy or GP unless at the patient’s request.
But recently, reports have emerged that nominations have been chang
Pharmacy Inside Jobs: sports pharmacist
In this episode of Pharmacy Inside Jobs, Joanna Robertson, senior clinical reporter, talks to Mark Stuart, a sports pharmacist whose 25-year career has spanned Olympic, Paralympic and Commonwealth games, as well as anti-doping education at the International Testing Agency.
Our conversation also touches on the growing use of supplements, how a pharmacist's expertise helps athletes think through ho
Lifeline: an antimicrobial resistance musical
In this episode of The PJ Pod, senior features editor Siobhan Chan examines how the issue of antimicrobial resistance (AMR) is being communicated outside of traditional clinical and policy settings.
The episode talks about Lifeline, a musical that brings together the history of antibiotics and the modern realities of drug-resistant infections.
We speak to two practising pharmacists who perform
What’s next for a community pharmacist prescribing service in England?
Over the past two years, around 200 community pharmacies in England have been involved in NHS England’s ‘Community pharmacy independent prescribing pathfinder programme’, trialling different clinical models to discover what a community pharmacy prescribing service could look like.
In this episode of The PJ Pod, senior clinical reporter Joanna Robertson shares on-the-ground reporting from two phar
The Royal College of Pharmacy: a new era
On 15 April 2026, the Royal Pharmaceutical Society became the Royal College of Pharmacy and — as Karen Baxter, the organisation's interim chief executive, says — that date “isn't the end of this story: it's just the foundation stone”.
In this episode of The PJ Pod, Baxter and outgoing chief executive Paul Bennett reflect on the journey up until this moment, the path that now lies ahead and the se
Pharmacy Inside Jobs: emergency department pharmacy
In this episode of Pharmacy Inside Jobs, Alex Clabburn, senior editor — research and learning, talks to Shane Kailla, a principal pharmacist and advanced clinical practitioner working in acute and emergency medicine.
Shane has worked as an emergency department pharmacist since 2021, with his current role focused on establishing the first dedicated pharmacy provision within a large NHS trust in th
Pharmacy Inside Jobs: astropharmacy
In this episode of Pharmacy Inside Jobs, senior features editor Siobhan Chan talks to Li Shean Toh.
Toh is an astropharmacist, who is currently based at Monash University in Australia and also holds roles at the UK Space Agency and European Space Agency. She carries out clinical consultations, research and teaching into medicines management and the way our bodies process medication in microgravit
Speaking up: how to raise concerns in the pharmacy workplace
This episode of The PJ Pod looks at the importance of speaking up whenever you have a safety or wellbeing concern, and how exactly to go about that. We speak to Beth Carter, interim director of operations and strategy at the National Guardians Office; and Mark Pitt, pharmacist and director of defence services at the Pharmacists’ Defence Association, who set out what anyone working in pharmacy shou
What will 2026 hold for pharmacy?
The PJ Pod’s final episode of the year looks ahead to our editorial team’s predictions for pharmacy in 2026. What big changes are coming for the world of pharmacy — and what impact will this have on pharmacists’ day-to-day work?
We also look at the biggest stories of 2025, including a new contract that was deemed the best deal in the past decade, the ten-year health plan and the greater role that
Migraine: what do pharmacists need to know?
Article Supported By
Pfizer
Financial support was provided from Pfizer Ltd. Pfizer have provided only financial support and have had no input into the development or content of the project and associated materials.
In this episode of The PJ Pod, senior editor Alex Clabburn shares insights from a recent expert round table meeting hosted and organised by The Pharmaceutical Journal exploring how pha
New chronic heart failure guidance: what does it mean for practice?
In this episode of The PJ Pod, we explore the main changes and implications for practice of the National Institute for Health and Care Excellence (NICE)’s chronic heart failure guidance update.
On 3 September 2025, NICE released its updated guidance on ‘Chronic heart failure in adults: diagnosis and management’.
The guidance mentions the role of pharmacy for the first time and has implications f
Pharmacy Inside Jobs: the pharmaceutical industry
In this episode of Pharmacy Inside Jobs, senior features editor Dawn Connelly talks to Sanjay Gudimetla.
Gudimetla has worked within the pharmaceutical industry for around nine years and is currently senior medical affairs manager at Jazz Pharmaceuticals. He is also a qualified final medical signatory.
Before moving to his role within the pharmaceutical industry, Gudimetla gained his independent
Pressures facing pharmacists in 2025
From rising stress to expanding clinical roles, pharmacists are facing mounting pressures.
Chronic understaffing combined with increased demand and limited resources are
compromising patient safety and leaving many pharmacists working alone or rushed.
Emotional strain is also growing, with reports of increased abuse and burnout.
Despite these challenges, pharmacists remain deeply committed to pa
Benefits of patient and public involvement in research
In this episode of The PJ Pod, we look at the benefits of effective patient engagement and speak to the OPERA 2025 shortlist and joint winners, to explore some of the ways that they are working patients and the public to improve the relevance, accessibility and quality of their work.
For links to further resources and sources of support when getting started in research visit the PJ website.
Ma
Pharmacy Inside Jobs: ADHD assessment and management
Our new PJ Pod series — Pharmacy Inside Jobs — has been developed to inspire you to take the next step in your career. Whether you are a pharmacy student or a seasoned pharmacy professional, our goal is to provide insights into the increasingly diverse roles that exist within the profession.
In each episode, we will be joined by a guest to explore their career journey so far, with a focus on thei
Pharmacy Inside Jobs: prison pharmacy
Our new PJ Pod series — Pharmacy Inside Jobs — is aimed to inspire you to take the next step in your career. Whether you are a pharmacy student or a seasoned pharmacy professional, our goal is to provide insights into the increasingly diverse roles that exist within the profession.
In each episode, we will be joined by a guest to explore their career journey so far, with a focus on their current
First UK joint asthma guidance: what does it mean for practice?
On the 27th of November 2024, the British Thoracic Society (BTS), National Institute for Health and Care Excellence (NICE) and Scottish Intercollegiate Guidelines Network (SIGN) released joint guidance on ‘Asthma: diagnosis, monitoring and chronic asthma management’. The guidance is the first collaboration of its kind between the organisations.
The guideline makes a number of recommendations,
Spotlight: MPharm ethnicity awarding gap rewidens
The Pharmaceutical Journal’s third analysis of MPharm awarding gap data has revealed that the percentage point difference between the proportion of white students and minority ethnic students awarded a first or 2:1 degree increased to 11 percentage points in 2021/2022 and 2022/2023.
This comes after previous analyses of the data from before and during the pandemic indicated a narrowing of the gap
Disagreement and conflict in teams
Disagreement and conflict are unavoidable realities common to all working environments, but for pharmacists and pharmacy teams faced with potentially long hours, stretched resources, increasing complexity and high expectations, it does not take much for problems to escalate. This can put patient safety at risk and contributes to stress and burnout.
In this learning episode of The PJ Pod, we expl
Spotlight: Palliative care access
Despite national incentives and locally commissioned services designed to improve availability of palliative care medicines from community pharmacies, access is not evenly distributed across the country.
This problem is only set to get worse with demand for these services expected to increase in the coming decades. Marie Curie has estimated that, if the proportion of people requiring palliative c
Looking back at 2024: a review of the biggest stories in pharmacy
As has become tradition, The PJ Pod’s final episode of the year looks back over some of the most significant stories in pharmacy in the past 12 months, before members of The PJ editorial team make their predictions for 2025.
Big stories of 2024 have included the launch of Pharmacy First in England, a persistent ethnicity pay gap in the profession, the emerging threat of nitazines, slumping vaccin
Your views on the Royal Pharmaceutical Society's royal college proposals
In September 2024, the Royal Pharmaceutical Society (RPS) put forward proposals to take on royal college status, pending a vote of the membership in early 2025.
The RPS said the proposals were in response to strategic ambitions amid rapid changes in the pharmacy profession, and followed an independent, 18-month-long review of its constitution and governance, led by consultancy firm Firetail.
To
Spotlight: Safety of time-critical medicines
High levels of patient safety incidents related to time-critical medicines (TCMs) — medicines that need to be given or taken at a specific time — have persisted for decades. In 2022/2023 alone, there were 17 deaths recorded as a result of medicine dose delivery being delayed or omitted entirely.
Solutions, such as using e-prescribing systems, has been successful on a local level but scaling them
Prescribing nature to boost mental health
Green social prescribing, which can include activities such as community gardening, mindful walks and conservation volunteering — as well as 'blue' activities like kayaking and wild swimming — is gaining traction.
Results from a government-backed green social prescribing programme were published in September 2024, showing that it had a positive impact on measures of wellbeing and was able to reac
How can pharmacists best support patients with chronic lymphocytic leukaemia?
Over the last decade, the development of targeted therapies has significantly changed the way that chronic lymphocytic leukaemia (CLL) is treated. Survival and life expectancy has improved, and this patient cohort is living and receiving treatment for longer than ever before. These changes have meant that the involvement of pharmacists across all sectors in the treatment of CLL patients has also e
Changes in migraine treatment: how new classes of drugs can offer options for patients & prescribers
In this learning episode, we look at the latest developments in migraine treatment where new classes of drugs are starting to provide additional options for patients and prescribers.
For links to relevant articles and further resources on migraine treatment visit the PJ website.
Many thanks to Kerri Spalding, a migraine patient, advocate and fundraiser, and Mathew Garrod, lead pharmacist for n
Medical drone deliveries: a viable option for the NHS?
Drones are already being used to transport medicines in several countries around the world, including the United States, Australia, Switzerland and Rwanda, but what’s the story in the UK, where the road infrastructure is good and the airspace is small and busy? Is there a need for medical drone deliveries? Are they safe and would they be a viable option for the NHS?
These are questions that senio
Getting into research
In this episode of The PJ Pod, we look at how pharmacists can become more involved in research, by hearing directly from those who have done just that. We speak to the members of our OPERA 2024 shortlist, and winner, as well as Parastou Donyai, chief scientist at the Royal Pharmaceutical Society, to explore some of the practical steps that individuals can take when starting out, while also conside
Spotlight: Pharmacists in community mental health teams
The ‘NHS mental health implementation plan 2019/20–2023/24’, published by NHS England in July 2019, identified a need for “new and integrated models of primary and community mental health care” to support 370,000 adults and older adults with severe mental illness (SMI).
With many of these patients on psychotropic medication, such as clozapine, lithium, valproate and antidepressants, to treat a ra
Pharmacy under fire: managing medicines in war zones
Please note that this episode includes discussions of war and injury that may be distressing to some listeners, with stories from pharmacists working in Sudan, Ukraine and Gaza.
Horrific stories of injury and death in war zones across the world have become a staple of daily news headlines since the invasion of Ukraine in February 2022. In an effort to help, the UK government and grassroots organi
Revisiting 2023: a look back at the year in pharmacy
As we reach the end of 2023, this final podcast episode of the year continues our annual tradition of looking back at the biggest stories to affect pharmacy teams across the UK, while reflecting on our highlights from The PJ Pod over the past 12 months.
While 2023 has been a significant year for pharmacy, with the announcement of a new NHS 'Pharmacy First' service in England and accelerating plan
Becoming a pharmacist prescriber: the highs and lows
From 2026, all pharmacists will be independent prescribers when they first qualify. But that leaves a whole cohort of non-prescribing pharmacists already in the workforce, many of whom do not want to be left behind.
In this episode of The PJ Pod, we accompany three pharmacists — Isabel Macho and Isheeta Mendiratta, who work in primary care, and community pharmacist Rachael Patel — as they train t
Spotlight: Homecare services in crisis
In November 2023, an investigation by The Pharmaceutical Journal revealed that two-thirds of patient safety incidents related to homecare medicine provision were for services provided by the company Sciensus, according to the latest data provided by NHS trusts.
The findings came after the House of Lords Public Services Committee opened an inquiry into homecare medicines services in May 2023, foll
Spotlight: Deprescribing research
The term 'deprescribing' refers to the tapering, stopping, discontinuing, or withdrawing of medications for the benefit of patients. It was first used 20 years ago in an article titled 'Deprescribing: achieving better health outcomes for older people through reducing medications' by Michael C. Woodward. Since then, the body of literature has exploded.
In this 'spotlight' episode of The PJ Pod, we
BTK inhibitors: what pharmacists need to know
Bruton tyrosine kinase (BTK) inhibitors are used to treat cancers caused by defective B cells, such as chronic lymphocytic leukaemia, B-cell lymphomas and Waldenström macroglobulinemia (WM). While B-cell malignancies are relatively rare cancers, their incidence is increasing. There are significant side effects and drug interactions associated with these therapies, and as the clinical use of BTK in
Spotlight: the story behind the ADHD prescribing surge
In June 2023, The Pharmaceutical Journal revealed that the number of adults in England prescribed medicines for attention deficit hyperactivity disorder (ADHD) has more than doubled since January 2020.
The increase, which was particularly pronounced in females, has been largely fuelled by increasingly frequent opportunities for adults to pinpoint the symptoms of ADHD in themselves, either as a re
End-of-life drugs at home: closing the care gap
Medicines play a critical role in ensuring that people at the end of their lives, and their carers, can manage symptoms, including pain, and remain comfortable at home.
But there is evidence that the systems supplying these medicines are difficult, complex and often lead to delays in vital care that leave patients in unnecessary suffering. This in turn can increase costs for the NHS if these pat
Spotlight: Questions over Pharmacy First
The UK government has said it will introduce a ‘Pharmacy First’ service for England by the end of 2023, as part of a plan for recovering access to primary care.
Negotiations are ongoing, but the new service is designed to enable pharmacists to supply medicines for seven common health conditions, including earache, sore throat and urinary tract infections. However, it is not clear whether communit
Psychedelic drugs: the new frontier for mental health
***Warning: this episode contains some potentially upsetting content about suicidal thoughts and miscarriage. If you would like to skip this part please fast forward from 09:50 to 17:00***
Julia Robinson speaks with experts in the field of psychedelics and mental health, and hears the personal account of someone with first-hand experience of participating in one of these trials, to uncover the tr
Spotlight: The truth about weight-loss injections
So-called ‘skinny jabs’ have been heralded as game-changers for weight management.
Wegovy (semaglutide) is due to be launched in the UK imminently, will soon be available from community pharmacies, with large chains already setting up waiting lists for people wanting to get the weekly injection privately.
In this episode, Nigel Praities, executive editor, talks with Dawn Connelly and Emma Wilkin
Coping with the ‘Davina effect’ on HRT
TV personality Davina McCall has been at the forefront of a much-needed sea change in the awareness of menopause symptoms, leading to many more women seeking HRT.
However, as demand as risen, there have also been major shortages of certain products and there have also been claims that, in some cases, hormone therapies are being overprescribed.
In this episode, Katherine Sole and Julia Robinson s
Spotlight: Ethnicity and the pharmacy degree
In this second Spotlight episode, we talk through an investigation that has shown the awarding gap between white pharmacy graduates and their ethnic minority counterparts in the UK has narrowed during the COVID-19 pandemic.
PJ journalists Dawn Connelly and Corrinne Burns share the inside story on how they put the investigation together, what the results show and their potential implications for m
Effective deprescribing: getting the most from medicine
In this learning episode, we have enlisted the help of two experts to explore what it takes to deliver effective deprescribing and ask what pharmacists can do to help patients get the most from their medicines.
For links to relevant articles and further resources on deprescribing visit the PJ website: https://pharmaceutical-journal.com/article/feature/effective-deprescribing-getting-the-most-from
Spotlight: The ‘new thalidomide’
In the UK, three babies are still being born each month after being exposed to sodium valproate. This is despite the risk of foetal valproate spectrum disorder being known about for many years.
In the first of a series of shorter ‘Spotlight’ episodes, executive editor Nigel Praities speaks with senior data journalist, Julia Robinson, about her recent investigation into this issue and whether NHS
Building bridges: pharmacists reaching out to help their communities
The COVID-19 pandemic has starkly exposed how inequalities in health can be affected by factors such as ethnicity, gender or geography — and all the evidence points to these getting worse.
But in this episode, we hear from two pharmacists trying to turn this around.
First, Ade Williams, superintendent pharmacist at Bedminster Pharmacy in Bristol, explains how he used a "Pulse in the Pub" blood p
What will be the big stories in 2023?
Will pharmacists go on strike over pay? Will medicines shortages improve? What will be the biggest clinical developments next year?
The team unpicks some of the biggest pharmacy stories of 2022 and shines a light on what pharmacists should expect in the coming 12 months.
Please do let us know what you think we have missed in this episode on social media, using the hashtag #PJPod. See you next ye
What does it take to become a consultant pharmacist?
Two years since the Royal Pharmaceutical Society (RPS) took on responsibility for approving consultant pharmacist posts, we look at how these roles are evolving.
We also ask how many consultants the profession needs, look at the barriers to reaching this level of practice and explore how the path to becoming a consultant could be made easier.
Thanks to Hannah Beba, consultant pharmacist in diabe
Anticholinergic drugs and dementia: a causal link?
Anticholinergic drug use is on the rise due to the COVID-19 pandemic and the UK medicines regulator is also considering extending access to the anticholinergic bladder drug oxybutynin over the counter.
In this episode, we will look at the potential implications of these changes, particularly in older people, and examine the case for deprescribing. We will also assess emerging evidence that sugges
Immune-related cancer toxicities: what pharmacists need to know
In this episode, Caitlin Killen, assistant clinical editor, and Alex Clabburn, senior editor, enlist the help of two experts to explore what the rise in immunotherapy treatment means for the ongoing care of cancer patients.
Many thanks to Dharmisha Chauhan, lead genomic clinical pharmacist for North Thames Genomic Medicine Service Alliance and specialist oncology pharmacist at The Royal Marsden N
NICE type 2 diabetes update: what do you need to know?
In this episode, assistant clinical editor Caitlin Killen, looks at the practical implications of a recent update to NICE guidance on diabetes treatment in adults, with the help of two experts.
Many thanks to Michelle Lam, pharmacy team leader for education & training at St George’s University Hospitals NHS Foundation Trust, and Sallianne Kavanagh, an advanced clinical pharmacist at Sheffield Tea
Pharmacogenomic testing: coming to a community pharmacy near you
What if you could pop into your local pharmacy to get tested for how your genes affect the way you metabolise drugs, such as statins or antidepressants? In several countries, you can.
Features editor Dawn Connelly travels to those countries and speaks with community pharmacists that are already providing this routinely. She starts by visiting the Netherlands, where she talks to Fleur van Gelder
Myth-busting acute pain and its treatment
Which combination is most effective? Should I take this with food? The public often ask for advice on how to treat acute pain conditions, such as headaches, period pain or soft tissue injuries.
At first glance, it may seem straightforward; however, there are some common misconceptions around the changing evidence in this area.
In this episode, Caitlin Killen, assistant clinical editor, and Nigel
Pandemic plus? The antibiotic resistance lurking in our rivers
In this episode, Carolyn Wickware, investigations editor, looks at the emerging evidence that UK rivers are becoming a dangerous ‘breeding ground’ for bacteria resistant to antibiotics that could adversely affect human health.
Alistair Boxall, professor of environmental science at the University of York, describes his concerns over the level of antibiotics that he has measured in our water system
Can antiviral drugs turn the tide on COVID-19?
There have been claims that COVID-19 oral antivirals, such as molnupiravir and Paxlovid (nirmatrelvir + ritonavir), will “change the course of the pandemic”.
But with limited supply, a short treatment window and only a few patient groups eligible to receive them — can these drugs really turn things around?
In this episode, Dawn Connelly, features editor, and Julia Robinson, clinical and science
Apprentice pharmacists: could they help reduce shortages?
In this episode, we explore the arguments for and against the planned introduction of degree apprenticeships as an alternative for the traditional MPharm degree in England.
Reporter Corrinne Burns speaks with Mark Koziol, chair of the Pharmacists’ Defence Association, who is sceptical about the benefits for future pharmacists.
Exploring the other side of the argument, Nick Hillman, director of t
2021 unwrapped: the year in pharmacy
In our last PJ Pod of the year, we eat some mince pies and ruminate over what has been a momentous 12 months in the history of the pharmacy profession.
We also stake our journalistic reputations on some predictions of what might be the big news for pharmacists in 2022. Should pharmacists in the NHS be preparing for industrial action over pay? What will health secretary Sajid Javid's next move be?
Pale and stale: decolonising the pharmacy degree
Over the past few years, pharmacy student Adanna Anthony-Okeke has been leading a project to "decolonise" the curriculum at the University of Nottingham’s school of pharmacy.
In this episode, we speak to her and MPharm course leader Helen Boardman about how this work has led to significant and ongoing change to the syllabus.
Clinical and science editor, Julia Robinson, also investigates the prog
Will ranitidine ever make a comeback?
Stomach acid-suppressing medicine ranitidine disappeared from pharmacy shelves two years ago, owing to fears of contamination with probable human carcinogen N-nitrosodimethylamine (NDMA).
In this episode, features editor Dawn Connelly finds out why.
She speaks with David Light, chief executive officer of Valisure, the online pharmacy that first identified the contamination in ranitidine, and M
Antidepressant withdrawal: why has it been ignored for so long?
Until recently, the withdrawal symptoms some people experience after stopping an antidepressant were not recognised as a serious problem.
However, they can be extremely distressing, and so patients have been forced to set up their own online support groups to share information how best to taper antidepressant doses.
In this episode, executive editor Nigel Praities talks with Adele Framer, founde
Meet the mAbs: the new treatments for vulnerable patients with COVID-19
There have been some promising trial results recently regarding the efficacy of monoclonal antibodies (or mAbs) in patients with COVID-19.
In this podcast, features editor Dawn Connelly and clinical and science editor Julia Robinson investigate the science behind these exciting new treatments and the potential role of pharmacists in preparing, supplying and assessing patients for their use.
Robi
Pharmacy’s mental health crisis: building back better post-pandemic
The stress and uncertainty of the COVID-19 pandemic has had a detrimental impact on everyone’s mental health; however, the impact on frontline healthcare workers has been particularly acute.
For some of these individuals, it will have a long-lasting effect and they may require support for a number of years to come.
In this podcast, Julia Robinson investigates the experiences of pharmacists redep
Is Amazon Pharmacy really a threat?
Amazon has been shaking up the US pharmacy market during the COVID-19 pandemic, and has just been granted a trademark in the UK.
In this podcast, deputy news editor Carolyn Wickware looks at whether Amazon Pharmacy really is a threat to community pharmacies in the UK, which is a very different market to the US.
Wickware speaks with the CEO of McKesson UK, Toby Anderson, about its progress on imp
Shattering the silence on hidden disabilities in pharmacy
This podcast uncovers the problem of ‘hidden disabilities’ in pharmacy, and what can be done to make the profession more supportive for those with health conditions, such as hearing or mobility issues, that may be hard to see.
We speaks with two pharmacists, Nalwenga Mutambo and Aamer Safdar, about their experiences working as a pharmacist with a hidden disability and how they came to the realisa
Proregs, the pandemic and a 'new normal' for pharmacy training
Over the past year, the disruption caused by the COVID-19 pandemic for those trying to enter the pharmacy profession has been profound.
In this podcast, we investigate how pharmacy’s own “Generation COVID” is feeling, with two recording audio diaries in the weeks leading up to their long-delayed registration assessment.
Proregs Regan McCahill and Andrew Moy share their day-to-day lives, thought
COVID-19 vaccines: your questions answered (part 2)
With three COVID-19 vaccines approved in the UK, the focus is now shifting towards how the vaccination programme is being rolled out
This podcast picks up where we left off in our previous one, answering a new set of readers questions submitted through the PJ website and social media.
Nigel Praities, executive editor, Dawn Connelly, features editor, and Julia Robinson, clinical and science edit
Cannabis on the NHS: a missed opportunity?
Recently, it emerged that Billy Caldwell — the young boy who sparked a change in the law over medical cannabis — has received an NHS prescription for the cannabis oil to treat his severe epilepsy.
However, two years after its legalisation, Billy is only one of a handful of patients who have received an NHS prescription for medical cannabis in the UK. This is despite many thousands of patients usi
COVID-19 vaccines: your questions answered
We asked PJ readers to submit their questions regarding the different COVID-19 vaccines being developed around the world, the phase III trial results and the practicalities of how these vaccines will be administered.
In this podcast, Dawn Connelly, features editor and Julia Robinson, clinical and science editor, will try to answer these questions using the latest available information and the hel
Post-pandemic pharmacy: a brave new world?
This podcast celebrates the shortlisted entries to The Pharmaceutical Journal's 2020 writing competition.
Hosted by executive editor Nigel Praities and opinion editor Abigail James, we hear all the shortlisted entrants read out their pieces, give an insight into what makes a winning entry and announce the winners!
MPharm awarding gap: how can BAME students be better supported?(part 2)
Senior staff at two UK pharmacy schools - Reading and Wolverhampton - outline how they are tackling their ethnicity awarding gaps for MPharm degrees and the head of education at the General Pharmaceutical Council explains how its new standards may help improve the situation.
Looking outside of pharmacy, our careers editor Angela Kam also speaks with a recognised expert in how universities can tac
MPharm awarding gap: what BAME students experience at university (part 1)
Careers editor Angela Kam speaks with four ethnic minority students about their experiences of going to university to study pharmacy and explores new evidence there is an "awarding gap" between them and white students studying the MPharm degree.
Publications officer at the British Pharmacy Students Association, Isobel Lowings, also speaks about her organisation’s position on the ethnicity awardi
Recommended
Trauma Bonding to Secure Relationship
Golden's Oldies
Lucy & Sam's Perfect Brains
The ADHD Adults Podcast
RHISE: Real History in Simple English (B2-C1, British)
Swingers
Messy Social Work
Africa's not for Wimps
Outsiding
Why? with Emma Kennedy
The English Podcast
British English Listening Practice - English Go! Podcast
